modulates TNF-␣-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner. Am J Physiol Gastrointest Liver Physiol 293: G1196 -G1204, 2007. First published October 4, 2007; doi:10.1152/ajpgi.00330.2007.-Cyclooxygenase (COX)-2 is increased in human chronic pancreatitis. We recently demonstrated in a model of chronic pancreatitis (WBN/Kob rat) that inhibition of COX-2 activity reduces and delays pancreatic inflammation and fibrosis. Monocyte chemoattractant protein (MCP)-1 mRNA and PGE 2 were significantly reduced, correlating with a decreased infiltration of macrophages. MCP-1 plays an important role in the recruitment of macrophages to the site of tissue injury. The aim of our study is to identify mechanisms by which macrophages and acinar cells maintain an inflammatory reaction. The expression profile of E prostanoid receptors EP 1-4 and MCP-1 was analyzed by RT-PCR from pancreatic specimens and AR42J cells. MCP-1 secretion was detected by ELISA from rat pancreatic lobuli. We determined EP1-4 mRNA levels in WBN/Kob rats with chronic pancreatic inflammation. Individual isoforms were highly increased in rat pancreas, concurrent with MCP-1 mRNA expression. In supernatants of pancreatic lobuli and AR42J cells, MCP-1 was detectable by ELISA. In the presence of TNF-␣, MCP-1 was upregulated. Coincubation with PGE 2 enhanced the TNF-␣-induced MCP-1 synthesis significantly. Similarly, TNF-␣ mRNA was synergistically upregulated by TNF-␣ and PGE 2. Furthermore, the synergistic effect of TNF-␣ and PGE 2 was abolished by inhibition of PKA but not of PKC. We conclude that EP receptors are upregulated during chronic pancreatic inflammation. PGE 2 modulates the TNF-␣-induced MCP-1 synthesis and secretion from acinar cells. This synergistic effect is controlled by PKA. This mechanism might explain the COX-2-dependent propagation of pancreatic inflammation. chronic pancreatitis; monocyte chemotactic protein-1; tumor necrosis factor-␣; E prostanoid receptors 1-4 SEVERAL STUDIES INDICATED that cyclooxygenase-2 (COX-2) is increased in human chronic pancreatitis (CP; Refs. 20, 32). A COX-2 selective inhibitor used in a rat model of CP (WBN/ Kob rats) significantly reduced and delayed inflammation and fibrosis. This correlated with markedly decreased levels of PGE 2 and decreased infiltration of macrophages. In untreated WBN/Kob rats with chronic inflammation, mRNA levels of both COX-1 and -2 isoforms were highly increased compared with healthy Wistar rats. COX-2 immunoreactivity was localized to inflammatory foci and found in macrophages (29).
induced during the inflammatory process. PGE 2 is a potent mediator of the inflammatory response and is known to stimulate cell migration and proliferation while inhibiting cell death through four different E prostanoid receptors (EP [1] [2] [3] [4] ; Ref. 3) . These receptors are coupled to G proteins. EP 1 causes an increase of free Ca 2ϩ and activates PKC. EP 2 and EP 4 are coupled to G s, which activates adenylyl cyclase to increase the cellular cAMP level and activates PKA. The intracellular pathway of EP 3 relays its signal through G i , which inhibits adenylyl cyclase (8) . More interestingly, PGE 2 induces COX-2 expression via EP 2 /cAMP response element activation in human pancreatic adenocarcinoma cell (27) . A number of reports point out a correlation between inflammation in the pancreas and eicosanoid levels including PGE 2 during acute pancreatitis (11, 37) . In the early phase of pancreatitis, PGE 2 appears to be increased in the tissue (11) . In contrast, plsama levels of PGE 2 were signifcantly reduced during necrotizing acute pancreatitis in the rat (37) . However, particularly in chronic pancreatic inflammation, the mechanism of the PGE 2 -mediated reaction, as well as the localization of receptors for PGE 2 , remains unclear.
Experiments using the COX-2 inhibitor in the WBN/Kob rat also demonstrated a significant downregulation of monocyte chemotactic protein-1 (MCP-1) in the pancreas compared with the untreated controls (29) . MCP-1 belongs to the C-C subfamily of chemokines and exerts strong chemotactic activity on monocytes, macrophages, and lymphocytes (30) . There are a number of cytokines that induce expression of MCP-1 (22, 39) . In murine mast cells, PGE 2 promotes release of MCP-1 (25) . Pancreatic acinar cells produce MCP-1, which is increased after cerulein stimulation (4, 9, 15) . Increased expression of MCP-1 has been shown in lesions of several fibrotic diseases including CP (2, 12, 31) , while Bindarit, a blocker of MCP-1 synthesis, is partially protective in mice with acute pancreatitis (6) . The correlation between the presence of COX-2 transcripts, prostaglandins, and MCP-1 suggests a potential role for PGE 2 in the regulation of MCP-1 (29) .
In this study, we used the WBN/Kob rat model with or without COX-2 inhibitor treatment, in vitro cell cultures of AR42J cells, and freshly prepared rat pancreatic lobuli to answer the questions: 1) Are PGE 2 and EP receptors involved in chronic pancreatic inflammation? 2) Is MCP-1 upregulation in acinar cells PGE 2 dependent? 3) Do acinar cells play an active role in the propagation of inflammation?
Here we demonstrate that EP receptors are highly upregulated in chronic pancreatic inflammation with the potential to mediate PGE 2 signaling. Furthermore, we show that prostaglandins can modulate, via PKA, the induction of proinflammatory cytokines and chemokines such as MCP-1 and TNF-␣.
MATERIALS AND METHODS
Chemicals. PGE2 and polyclonal antibodies to EP1-4 were purchased from Cayman Chemical (Ann Arbor, MI). Murine recombinant TNF-␣ was purchased from R&D Systems (Abingdon, UK), and stock solutions were prepared following manufacturer's recomendations and then diluted in cell culture medium. Cell culture medium and supplements were purchased from Invitrogen Life Technologies (Carlsbad, CA). Cell culture plastic wares (TPP) were obtained from Fisher Scientific (Wohlen, Switzerland). Rabbit polyclonal antibodies against rat MCP-1 and normal purified rabbit and goat IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and rabbit monoclonal antibodies against rat cAMP response elementbinding protein (CREB) and specific phospho-CREB (Ser133) were purchased from Cell Signaling (Boston, MA). The selective inhibitors for PKA (H-89; PKA: IC 50 ϳ 50 nM) and PKC (GF109203; PKC: IC50 ϭ 20 nM; PKA: IC50 ϭ 2.0 M) were purchased from Biomol (Plymouth Meeting, PA). Stock solutions for inhibitors were prepared in DMSO and freshly diluted into cell culture medium before use.
Cells and cell culture. The Wistar rat pancreatic acinar cancer cell line AR42J was obtained from American Type Culture Collection (Manassas, VA) and was used to simulate the response of pancreatic acinar cells to cytokines and prostaglandins. AR42J cells were grown in F-12K (Kaighn's modification) medium supplemented with 20% heat-inactivated FBS, 50 U/ml penicillin G, and 50 g/ml streptomycin. The cells were cultured at 37°C in a humidified atmosphere (5% CO 2-95% air), and the medium was changed every 3-4 days. After the cells were rested overnight in 1% FBS containing cell culture medium, they were exposed to selected factors as described in RESULTS. Supernatants were collected for additional analysis, and cells were harvested for RNA isolation or protein extraction, respectively.
Animals, isolation of rat pancreatic acini, and preparation of rat pancreatic lobuli. Animal treatment and specimen harvesting were reported previously (29) . Pancreatic acini isolations were performed from excised pancreas of Wistar rats after CO 2 asphyxiation. The pancreas was promptly removed, freed from fat, and chopped for 3 min in a Krebs-Ringer HEPES buffer on ice. The isolation of pancreatic acini was prepared using a previously described collagenase digestion method (1, 10, 13) . For each rat pancreas, 5 mg (ϳ7.5 U) of collagenase P (Roche, Rotkreuz, Switzerland) were used for digestion.
For pancreatic lobuli preparations, the chopped rat pancreas were then centrifuged, washed, and resuspended in F-12K/1% FBS medium.
Both pancreatic acini and lobuli were then plated in 12-well plates in F-12K/1% FBS medium. After being rested for 30 min, they were exposed to selected factors as defined in the RESULTS. The supernatants were collected, and the acini or the lobuli were homogenized for protein extraction or total RNA isolation. MCP-1 in supernatants and homogenates was detected by a commercial MCP-1 assay.
Preparation of total RNA and real-time PCR analysis. Total RNA was isolated and used for real-time PCR as described previously (7, 29) . TaqMan Gene Expression Assays based on the rat genes coding for EP 1, EP2, EP3, and EP4 were ordered from Applied Biosystems (Rotkreuz, Switzerland). Primers and probes for MCP-1 and TNF-␣ were used as described previously (24, 40) . Real-time PCR was run on a Taqman 7000 (Applied Biosystems) under standard conditions. Transcript levels were quantified using 18S RNA (Applied Biosystems) as a reference.
Western blot, immunohistochemistry, and ELISA. After the treatment periods, total protein was extracted and Western blotting was performed as described previously (35) . Immunohistochemistry protocols were as described previously (7, 29) . Thirty micrograms of total protein were used for detection of target antigen. The ECL detection system (GE Healthcare, Otelfingen, Switzerland) was used for detection. For measurement of rat MCP-1, supernatants of lobuli were collected, total protein was extracted from lobuli homogenized by sonification, and detection was carried out by a commercial rat MCP-1 ELISA assay (BD Biosciences, San Diego, CA) according to manufacturer's instructions. MCP-1 was normalized to the protein contents in homogenates of pancreatic lobuli.
Statistical analysis. Data are means Ϯ SE of three to seven separate experiments. ANOVA was used with the Bonferroni posttest when data were compared within one experiment. Student's t-test was used for comparisons between two means of repeated experiments. A P value of Ͻ0.05 was considered significant.
RESULTS

Presence of MCP-1 in the rat pancreas.
It has been shown that in murine mast cells PGE 2 promotes release of MCP-1 (25) . The observation that MCP-1 along with PGE 2 was strongly reduced in the pancreas of WBN/Kob rats after COX-2 inhibitor treatment (29) led us to determine whether there is a link between PGE 2 and MCP-1 expression.
First, we established that MCP-1 is expressed in the acinar cell of the pancreas as reported earlier (4) . An ELISA for MCP-1 detected the chemokine in homogenates of healthy pancreatic lobuli and in medium supernatants of lobuli and AR42J cells. Furthermore, MCP-1 expression was detected in the acinar cancer cell line AR42J using immunocytochemistry (data not shown) and by real-time PCR (see Fig. 5 ).
Do pancreatic acinar cells express E prostanoid receptors?
In the WBN/Kob rat model of chronic pancreatitis, COX-2 immunoreactivity was localized predominantly in macrophages (29) . COX-2 activity leads to the secretion of PGE 2 . If PGE 2 targets acinar cells, we would expect them to express EP receptors. To localize these receptors, we performed immunohistochemistry, using antibodies directed against the four known types of EP receptors. The presence of EP receptors in acinar cells was further investigated by real-time PCR using gene-specific probes for the four EP receptors. We compared relative expression levels in healthy Wistar rat pancreas, in freshly prepared pancreatic lobuli, and in the pancreatic acinar cell line AR42J.
mRNA coding for EP 1 , EP 2 , EP 3 , and EP 4 , was present in the pancreas of Wistar rats ( Fig. 2A) , in pancreatic lobuli (Fig. 2B) , and in AR42J cells (Fig. 2C ). Overall, a very similar expression pattern was observed in all specimens, with EP 3 being the dominant receptor subtype. The expression of EP 2 was nearly undetectable in AR42J cells (Fig.  2C) . To compare the expression between the samples, EP 3 mRNA levels are shown in Fig. 2D . Wistar pancreas and AR42J cells show similar levels, while freshly prepared lobuli exhibited a slightly increased expression. In summary, these data demonstrate the presence of EP receptors in pancreatic acinar cells and strongly suggest that the pancreatic acinar cell is able to mediate PGE 2 signaling and actively participate in inflammation.
E prostanoid receptors expression profile in the rat model. To examine a potential link between PGE 2 and MCP-1, we assessed whether EP receptors are regulated during chronic inflammation in the WBN/Kob rat. Real-time PCR for the four receptor subtypes demonstrated a strong upregulation of EP 1 , EP 2 , and EP 4 in WBN/Kob rat pancreas compared with Wistar rats (Fig. 3, A, B, and D) . EP 3 , the most abundant receptor subtype in Wistar rat pancreas, was not increased in the WBN/Kob rat (Fig. 3C) . EP 1 was 3-fold upregulated ( Fig. 3A ; P Ͻ 0.05), while EP 2 was upregulated 25-fold ( Fig. 3B ; P Ͻ 0.05), similar to EP 4 (15-fold; Fig. 3D ; P Ͻ 0.05). Furthermore, in all conditions tested, the expression of the receptors was significantly downregulated in rats fed a COX-2 inhibitor (Rofecoxib) even when compared with age-matched Wistar rats (Fig. 3 , A-D; P Ͻ 0.05). The differential expression of the four different EP receptors supports our hypothesis that PGE 2 and EP receptors play a critical role in the COX-2-dependent development of CP.
Does PGE 2 regulate the expression of MCP-1 in pancreatic acinar cells? To determine whether PGE 2 could modify the synthesis and secretion of MCP-1, freshly prepared pancreatic lobuli were used. Two time points were chosen to assess initial secretion (1 h after stimulation) and synthesis (4 h after stimulation).
TNF-␣ is highly upregulated in pancreatitis and may mediate the inflammatory reaction in the acinar cell (5, 16, 29) . Thus, we examined whether TNF-␣ alone or in combination with PGE 2 can induce MCP-1 expression. After 1 h of stimulation, neither PGE 2 (10 Ϫ9 M) nor TNF-␣ (100 ng/ml, 6 ϫ 10 Ϫ8 M) alone had an effect on MCP-1 secretion as determined by MCP-1 ELISA of supernatants. However, in combination, they synergistically increased the expression of MCP-1 significantly (P Ͻ 0.05; Fig. 4A ).
When the incubation period was prolonged to 4 h, secretion of MCP-1 was significantly enhanced in response to TNF-␣ (P Ͻ 0.05), while PGE 2 alone still had no effect. Again, in Fig. 2 . Analysis of EP1-4 mRNA levels in Wistar rat pancreas and cell cultures. Transcript levels were determined by real-time PCR using gene-specific probes and primers. EP2-4 levels were compared with EP1, which was arbitrarily set to combination, PGE 2 and TNF-␣ increased the secretion of MCP-1, with MCP-1 levels higher than in lobuli treated by TNF-␣ alone (Fig. 4B) . The level of MCP-1 in the homogenates of pancreatic lobuli demonstrated a similar profile as in the supernatants after 4 h of treatment with a significant increase in the presence of both TNF-␣ and PGE 2 (P Ͻ 0.05 vs. TNF-␣ alone; Fig. 4C ). This suggests that PGE 2 plays a modulatory role in TNF-␣-induced expression of MCP-1 in freshly prepared pancreatic lobuli.
Freshly prepared pancreatic lobuli consist predominantly of acinar cells but also contain duct cells and other cell types. To ensure that the observation of MCP-1 regulation was acinar cell specific, we sought a source that is not contaminated by other cell types. Although clearly a cancer cell, AR42J cells are capable of producing a number of pancreatic acinar cell products, e.g., amylase and trypsinogen. Therefore, we chose this cell line to recapitulate the experiments.
First, we examined whether either TNF-␣ or PGE 2 alone could induce MCP-1 expression. MCP-1 mRNA was upregulated ϳ160-fold by TNF-␣ (P Ͻ 0.05), while PGE 2 only slightly increased the levels of MCP-1 mRNA. Then, we investigated whether PGE 2 could enhance the TNF-␣-mediated induction of MCP-1 mRNA. In combination, these factors caused a further enhancement of MCP-1 expression (P Ͻ 0.05; Fig. 5A ).
As the acinar response to TNF-␣ resulted in a strong MCP-1 induction, we asked whether TNF-␣ expression is also modulated by PGE 2 in the acinar cells. First, the effect of PGE 2 on TNF-␣ expression was tested (Fig. 5B) . PGE 2 alone did not influence TNF-␣ mRNA. When AR42J cells were exposed to TNF-␣, a 6,500-fold upregulation of TNF-␣ mRNA was detected (P Ͻ 0.05). Presenting TNF-␣ in combination with PGE 2 at 10 Ϫ9 M caused a further significant increase in TNF-␣ production (35,000-fold; Fig. 5B ; P Ͻ 0.05). To ensure that TNF-␣ mRNA was actually translated and secreted, we assessed TNF-␣ contents in medium supernatants by using a commercial ELISA kit. A significant amount of TNF-␣ was released, roughly 50% of the TNF-␣ added as a stimulus (data not shown). Thus, we conclude that the proinflammatory fac- tors TNF-␣ and PGE 2 act on the acinar cell in a synergistic fashion.
Which EP-receptor-dependent pathway mediates the synergistic effect of PGE 2 and TNF-␣?
In both freshly prepared pancreatic lobuli and AR42J cells, we demonstrated a synergistic effect of PGE 2 and TNF-␣ on MCP-1 expression. The four EP receptors (EP 1-4 ) signal via different G proteins, either by activation or inhibition of adenylyl cyclase or by the inositol triphosphate pathway. EP 2 and EP 4 are known to mediate their signals through PKA while EP 1 uses PKC (8) . To examine which EP-dependent receptor pathway is activated, we exposed pancreatic lobuli to a selective PKA inhibitor (H-89, 30 M) or to a selective PKC inhibitor (GF109203, 0.5 M) in presence of TNF-␣ at 100 ng/ml and PGE 2 at 10 Ϫ9 M. As a positive control, lobuli were stimulated by TNF-␣ alone (P Ͻ 0.05) and by TNF-␣ combined with PGE 2 (P Ͻ 0.05) in the absence of inhibitors. After 4 h of stimulation, MCP-1 in supernatants was determined by ELISA. The synergistic effect of PGE 2 and TNF-␣ on MCP-1 expression was abolished by PKA inhibition (H-89, P Ͻ 0.05) but not by PKC inhibition (GF109203; Fig. 6A ) where MCP-1 was even slightly increased. Inhibition of PKA resulted in an MCP-1 expression equal to that after TNF-␣ stimulation alone, strongly suggesting that PKA may be responsible for the PGE 2 effect on MCP-1 secretion using either EP 2 and/or EP 4 .
Finally, we explored whether a substrate of PKA, cAMP responsive element binding protein (CREB), is phosphorylated. In untreated AR42J cells, phospho-CREB was practically absent with only a minor induction after TNF-␣ stimulation. In combination with PGE 2 , phospho-CREB was strongly enhanced and this effect was not abolished by the addition of an inhibitor of PKC. However, addition of a PKA inhibitor caused a reduction of phospho-CREB (Fig. 6B) . This further supports the observation that there is a crosstalk between E prostanoid receptors and TNF-␣ signaling leading to activation of CREB via PKA to modulate the synthesis/secretion of MCP-1, which plays a critical role in macrophage recruitment during CP development.
DISCUSSION
In this study, we have shown that the pancreatic acinar cell is highly responsive to TNF-␣. PGE 2 , a product of the COXcontrolled prostaglandin pathway, caused only minor induction of MCP-1. However, in the presence of TNF-␣, PGE 2 further enhanced the synthesis and secretion of MCP-1 in freshly prepared pancreatic lobuli as well as in the pancreatic acinar cancer cell line AR42J. We found that both EP receptors and MCP-1 are highly upregulated in chronic pancreatic inflammation in rats. EP receptors are differentially expressed with respect to their subtypes. PGE 2 modulated MCP-1 synthesis in pancreatic acinar cells through EP receptors by a PKA-dependent mechanism. Therefore, we propose that the acinar cell has an active role in the propagation of inflammation.
Chronic pancreatic inflammation, e.g., chronic pancreatitis, is characterized by a succession of inflammatory flares, leading to the destruction of the parenchyma (19) . To circumvent the difficulty to study early phases of CP in humans, rats or mice are often used as a model (26, 38) . Although these animal models do not reflect exactly the pathophysiology of human CP in every aspect, they still provide insightful information on the mechanism of chronic pancreatic inflammation. In the current experiments, we have studied WBN/Kob rats in the presence and absence of a COX-2 inhibitor, as well as AR42J cells and Wistar rat pancreatic lobuli, to examine the response of the acinar cell to proinflammatory mediators known to be secreted by macrophages. Activated macrophages induce COX-2, thereby enhancing the synthesis and secretion of prostaglandins (17, 34) . We have focused on PGE 2 , a known proinflammatory molecule (23) , that acts locally in a para-or autocrine manner. Our group (29) has recently shown that the application of a selective COX-2 inhibitor in WBN/Kob rats decreased the infiltration rate of macrophages in the rat pancreas in correlation with a decreased expression of MCP-1. In a model of acute pancreatitis, it was shown that application of Bindarit, a MCP-1 inhibitor, suppressed MCP-1 production and attenuated tissue injury in the pancreas (6, 41) . MCP-1 was also significantly increased in a rat model of CP induced by dibutyltin dichloride, supporting the hypothesis that this chemokine is an important mediator of inflammation (6, 41) . MCP-1 expression is also known to be increased in human CP (31) . We confirmed the presence of MCP-1 freshly prepared pancreatic lobuli and in the acinar cell line AR42J. These observations support a previous study (31) using in situ hybridization. TNF-␣ has also been localized to pancreatic acinar cells after exposure to cytokines (16) .
TNF-␣ and PGE 2 crosstalk. The role of PGE 2 as a modulator of the expression of MCP-1 was demonstrated in freshly prepared pancreatic lobuli after a 1-h treatment. Secretion of MCP-1 was only observed when PGE 2 and TNF-␣ were applied simultaneously, as either PGE 2 or TNF-␣ alone had no effect. When the incubation period was prolonged to 4 h, the effect was still observed; however, the role of PGE 2 now appeared to be modulatory. PGE 2 appears to sensitize the pancreatic aciniar cell to respond to cytokines such as TNF-␣ during inflammation. The difference between the early response (1 h) and the late (4 h) may be that initially PGE 2 acts on secretion, while later de novo synthesis may be induced. The data from AR42J cells confirmed the modulatory effect of PGE 2 on TNF-␣-induced expression of MCP-1 in pancreatic lobuli. Thus, the combined presence of PGE 2 and TNF-␣ might play a critical role in COX-2-dependent pancreatic inflammation.
The concurrent presence of TNF-␣ and PGE 2 is conceivably possible in a situation where macrophages and acinar cells are in close proximity. Interestingly, in the presence of PGE 2 , TNF-␣ significantly enhanced its own expression, although PGE 2 alone had no effect on the production of TNF-␣. This amplification of chemokines will possibly result in further attraction of inflammatory cells. The observed and discussed data imply that the pancreatic acinar cell can adopt an "inflammatory" state, which in itself propagates the inflammatory reaction. A summary of this concept is integrated in Fig. 7 . Acinar cell damage or impaired function leads to a chemokine release (e.g., MCP-1) that attracts monocytes. Concurrent release of TNF-␣ activates the monocyte to a macrophage. Activation leads to induction of COX-2, which results in increased PGE 2 secretion. TNF-␣ and PGE 2 together enhance the production of more MCP-1 (and TNF-␣) of acinar cells.
In contrast, PGE 2 has an inhibitory effect on chemokine production in macrophages. Several studies have shown that LPS-activated macrophages scerecte less TNF-␣ (28) and macrophage inflammatory protein 1␣ and 1␤ in the presence of PGE 2 (18, 36) . This modulatory effect may lead to a balanced reaction of the macrophages to the extent of tissue injury. In the concept shown in Fig. 7 , destruction of acinar cells will eventually lead to a reduction of acinar cell derived TNF-␣. Therefore, activated macrophages are exposed to PGE 2 , which they are able to secrete, and less TNF-␣. This shift of the balance between PGE 2 and cytokines may indicate that macrophage activity is not required and hence macrophage activation is subdued.
To examine the mechanism of PGE 2 signaling in pancreatic acinar cells, we investigated the expression of EP receptors in Wistar and WBN/Kob rat pancreas, in freshly pancreatic acini, and in the acinar cancer cell line AR42J. In contrast to pancreatic tissue and lobuli and AR42J cells, isolated pancreatic acini exhibited an ϳ10-fold higher expression of EP receptor mRNA (data not shown). Since the acinar cell is the predominant cell type, making up 80 -90% of the cell volume in the pancreas, the increase in EP receptor mRNA levels in pancreatic acini cannot be explained by the selective accumulation of acinar cells in this preparation. Although freshly isolated acini responded to and produced TNF-␣ (16), the modulatory effect of PGE 2 on TNF-␣, showing the same trend, was not significant. Hence, the increase in EP-receptor mRNA levels and lack of responsiveness are presumably the result of the method of acinar cell isolation, particulary due to collagenase digestion. This convinced us to use the more gentle production of pancreatic lobuli.
In WBN/Kob rats, we demonstrated that specific subtypes of EP receptors are significantly upregulated during CP. Particularly EP 2 -and EP 4 -mRNA were 15-to 25-fold more abundant in the pancreas of WBN/Kob rats compared with Wistar rats. However, EP 3, the receptor most abundant in acinar cells, was hardly affected. The expression of the four EP receptors is organ specific; therefore, the extent as well as the combination of recpetor isoforms may vary considerably. In the mouse, EP 3 is highly expressed in the kidney and uterus, while EP 4 is dominant in the ileum, uterus and thymus (33) . Similarly, in human tissue, the expression of EP 3 is most prominent in the kidney, pancreas, and uterus (21) . Since EP 3 is highly ex- pressed in the normal pancreas, we assume that it is responsible for homeostasis and normal physiological roles, while the regulated receptors EP 2 and EP 4 may be involved in pathophysiological processes.
PKA inhibition, but not PKC inhibition, abolished the synergistic effect of TNF-␣ and PGE 2 on MCP-1 expression in freshly prepared rat pancreatic lobuli. As it is known that the signal transduction pathway involving PKA is mediated predominantly by EP 2 and/or EP 4 (8, 14) , it is likely that these two receptors are responsible for the PGE 2 modulated TNF-␣-stimulated MCP-1 expression in pancreatic acini. Further support for a PKA-mediated effect is the phosphorylation of CREB. After activation of G s by the EP 2,4 receptor(s) cAMP is increased and subsequently PKA converts CREB to phospho-CREB. In the presence of PKA inhibitors, the synergistic effect of TNF-␣ and PGE 2 was abolished.
In conclusion, the parenchymal pancreatic acinar cell can be stimulated by cytokines to secrete chemokines and cytokines that attract inflammatory cells. This reaction can be propagated by the presence of PGE 2 , a COX-controlled proinflammatory mediator. A reduction of prostaglandin synthesis or inhibition of selective EP receptors by antagonists might therefore open therapeutic avenues for the treatment of human CP.
